swissnex Startup Bootcamps

Empowering Swiss Startups to Internationalize.

Startups


Empowering Swiss Startups to Internationalize

 

swissnex is the launchpad for Swiss startups in the US. Our equity-free startup programs are customized to the needs of entrepreneurs exploring or entering the US market. With over a decade of experience accelerating the international success of companies such as Mindmaze, faceshift, and Ava, we tailor our toolbox sessions to each startup and offer critical business connections. By joining our community of innovators, Swiss startups gain visibility and a home base to succeed in the US.

Twice a year, swissnex brings together promising Swiss Startups for a two week bootcamp with toolbox sessions, fireside chats, special networking events, a demo night, and more. However it is possible to come to swissnex SF year-round, just indicate your preferred dates in the application.

 

 

The next swissnex Startup Bootcamp takes place in Spring 2021 (the date will be announced shortly). Applications are now accepted.
Important: Applying startups need to be in the
Innosuisse coaching program

 


Participants of the virtual October 2020 bootcamp

ASPIVIX | Mathieu HORRAS, Co-founder & CEO | aspivix.com

Every year, more than 80M women worldwide experience pain, bleeding and tissue tear when undergoing common gynecological procedures that require uterus access. This trauma is generated by the Cervical Tenaculum, an instrument with sharp hooks that pinch the cervix to generate traction. ASPIVIX is changing that by developing a next-generation vacuum-based cervical device that delivers the same maneuverability as the tenaculum without the reported patient trauma. This device is ideal to help address unplanned pregnancies, considered one of the most significant global public health issues, by increasing the adoption of Intrauterine Contraceptive Devices (IUD), the most effective reversible contraceptive option available today. ASPIVIX empowers women and makes them free to choose their contraception option without fear. Find them on Facebook, Instagram, Linkedin, Twitter, and YouTube.


Auxivo AG
| Volker Bartenbach, Co-founder & CEO.  Michael Stucky, Co-founder & Chairman. Fabio Gobbo, Business Developer | auxivo.com

Auxivo is a spinoff from ETH Zurich developing the next generation of lightweight exoskeletons to improve workers‘ lives. Follow them on Facebook, Instagram, Linkedin, and Twitter.

JAMIE & I | Antonia Bolla, Founder | jamieandi.shop

Welcome to Your Personal Online Boutique with Sustainable Designers you’ll LOVE! Curated by Jamie, your personal artificially intelligent online stylist who curates your personal online boutique with a curated selection of sustainable designers tailored to your style. Follow them on Instagram, and Linkedin.

MYLEG | Giacomo Valle, Postdoctoral Researcher at ETHZ | p3.snf.ch

MYLEG is a non-invasive sensory feedback to improve Mobility and to promote cognitive prosthesis integration in people with leg amputation.

Neurosoft Bioelectronics | Nicolas Vachicouras, CEO & Karsten Bagger, CBO | neurosoft-bio.com

Neurosoft Bioelectronics develops implantable medical devices to interface with the brain and spinal cord to treat patients suffering from neurological disorders. Our main USP is that we are the only ones to have been able to combine extremely soft materials that match the mechanical properties of the nervous tissues with high-density electrodes. Thanks to these unique features, we can access some locations of the brain that are impossible to reach surgically otherwise. Our preliminary animal data also suggest that our soft electrodes reduce dramatically inflammation when implanted. Follow them on Linkedin and Twitter.

Optimo Medical AG | Harald P. Studer, CEO & Alexander van der Mey, CCO | optimo-medical.com

Optimo Medical AG is specialized in bio-mechanical analyses and simulation of the anterior eye. Since the companies founding in 2015, the team has built a steady reputation as the leading company in virtual trials for the anterior eye segment, and a global technology leader in patient specific astigmatism management. Follow them on Linkedin.

Scailyte | Peter Nestorov, CEO. Stefan Almestrand, Director Corporate Development. Andrius Serva, Business Development Manager. Agnieszka Sitarska, Business Development Associate | scailyte.com

Scailyte uses single cell technologies and AI to discover biomarkers for diseases in oncology and immunology. We have a number of patented biomarker signatures which we currently are developing into clinical diagnostic applications for hospitals and subsequently patients. Follow them on Linkedin.

 


What We Offer

 

 

 


Since 2010, we’ve supported 98 Swiss startups.

We integrate a community of over 400 founders and organizations.

Our startup alumni have a combined valuation of $1.1B, and have created more than 500 jobs.


In the press

A digital bootcamp for seven Swiss startups to explore the US market (Startupticker.ch – May 12, 2020)
A San Francisco startup guide for international entrepreneurs (Podium – August 13, 2019)
swissnex Startup Bootcamp: Off to San Francisco (Startupticker.ch – August 7, 2019)
Go Global: The swissnex Startup Roadshow in Switzerland (Startupticker.ch – May 14, 2019)
swissnex SF on CNN Money Switzerland (CNN – May 6, 2019)


Coaches & Speakers

Organizers

 

  • Franziska Steiner, organizer, swissnexSF
  • Linda Aerne, organizer, swissnexSF

Partners

Swiss Community

Startupticker.ch | The Swiss Startup News channel Startupticker.ch | The Swiss Startup News channel Atom-Feed: News

  • 1plusX secures fresh capital to bolster international expansion
    by Startupticker on January 20, 2021 at 3:50 pm

    Martech startup 1plusX designed a marketing intelligence platform to enable media companies and brand marketers to unlock the full potential of their data. The company will bring its solution to international markets, thanks to a $7.8 million capital increase obtained from the first closing of its series B round. Swisscanto Invest led the round.

  • Dating Group acquires Once for $18 million
    by Startupticker on January 19, 2021 at 4:04 pm

    Once, the leading app for quality dating in Western Europe with over 10 million users, is now part of Dating Group, one of the largest companies in the dating industry with 73 million registered users across its portfolio. The acquisition deal values the company at up to $18 million and is made via a combination of cash and Dating Group stock.

  • Qiibee builds loyalty program for Swiss luxury watch brand
    by Startupticker on January 18, 2021 at 3:45 pm

    The traditional Swiss watch brand Louis Erard relies on the blockchain for its loyalty program. Qiibee wins a renowned customer with the Maison based in the Jura mountains and founded in 1929.

  • Swiss startups unveil new solutions at CES 2021
    by Startupticker on January 13, 2021 at 3:02 pm

    The annual CES trade fair is a global platform for innovators to showcase and launch new consumer solutions. The Swiss startups, Leman Micro Devices, Biospectal and Typewise have, within this framework, revealed new solutions and product advancements. Mictic announced its move to establish a presence in Southern California.

  • Promising therapy for patients with spinal cord injuries advances to the next stage
    by Startupticker on January 13, 2021 at 12:30 pm

    ONWARD, formerly known as GTX Medical, announced the enrollment of the first patient in a pivotal trial in the U.S. evaluating its ARC Therapy. The pivotal trial, known as Up-LIFT, will assess the safety and effectiveness of ARC Therapy in restoring hand and arm function in people with spinal cord injury.